Terelak-Borys Barbara, Liberek Iwona
Kliniki Okulistyki Centrum Medycznego Kształcenia Podyplomowego w Warszawie.
Klin Oczna. 2007;109(1-3):64-7.
The aim of this article is to present current opinion on aqueous humor dynamics regulation and antiglaucoma drugs mechanisms of action. Pharmacotherapy of glaucoma is based mainly on neuro-hormonal processes controlling aqueous humor dynamics. Systemic hormones as well as local hormones and autonomic nervous system mediators are involved in the processes of aqueous humor formation and drainage. Antiglaucoma medications act mainly through activation or inhibition of these systems' receptors, helping to decrease aqueous humor production or improve aqueous humor outflow. In this article (part 2) we describe two groups of antiglaucoma medications (parasympathicomimetics, prostaglandin analogues), inhibiting the aquoeus humor outflow and mechanisms of their hypotensive effect in the eye.
本文旨在阐述关于房水动力学调节及抗青光眼药物作用机制的当前观点。青光眼的药物治疗主要基于控制房水动力学的神经激素过程。全身激素以及局部激素和自主神经系统介质都参与房水生成和引流过程。抗青光眼药物主要通过激活或抑制这些系统的受体发挥作用,有助于减少房水生成或改善房水流出。在本文(第2部分)中,我们描述了两类抗青光眼药物(拟副交感神经药、前列腺素类似物),它们抑制房水流出及其在眼部的降压作用机制。